New Year Bumper Sale @ Rs. 1 X
Larenase 0.25 Mg Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Schizophrenia. Other than this, Larenase 0.25 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Larenase 0.25 Mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Larenase 0.25 Mg Tablet as well, which are listed below. These side effects of Larenase 0.25 Mg Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Larenase 0.25 Mg Tablet's effect during pregnancy is Moderate and Severe while nursing. Further, the section on Larenase 0.25 Mg Tablet related warnings talks about Larenase 0.25 Mg Tablet's effects on the liver, heart and kidney.
Larenase 0.25 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Larenase 0.25 Mg Tablet in conditions like Depression, Arrhythmia, Bradycardia (Slow Heart Rate). Other conditions have been mentioned below in the Larenase 0.25 Mg Tablet contraindications section.
Additionally, Larenase 0.25 Mg Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Larenase 0.25 Mg Tablet is not safe while driving, and is is not addictive in nature.
Larenase 0.25 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Larenase 0.25 Mg Tablet safe for pregnant women?
Larenase may have some side effects during pregnancy. Pregnant women should discontinue the use of Larenase, and talk to their doctor, if they notice any discomfort.
Is the use of Larenase 0.25 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Larenase. So it is adviced to consult the doctor before using it.
What is the effect of Larenase 0.25 Mg Tablet on the Kidneys?
Larenase does not damage the kidneys.
What is the effect of Larenase 0.25 Mg Tablet on the Liver?
Side effects of Larenase rarely affect the liver.
What is the effect of Larenase 0.25 Mg Tablet on the Heart?
Larenase has very mild side effects on the heart.
Larenase 0.25 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Larenase 0.25 Mg Tablet unless your doctor advises you to do so -
Is this Larenase 0.25 Mg Tablet habit forming or addictive?
Larenase 0.25 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Larenase 0.25 Mg Tablet as you may feel sleepy.
Is it safe?
Larenase 0.25 Mg Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Yes, this Larenase 0.25 Mg Tablet works for mental disorders.
Interaction between Food and Larenase 0.25 Mg Tablet
It is safe to take Larenase 0.25 Mg Tablet with food.
Interaction between Alcohol and Larenase 0.25 Mg Tablet
Consuming Larenase 0.25 Mg Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 633-634
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 441
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Haldol® (haloperidol)